Companies Ditch Fluorescent Lights in Battle for Office Return
Offices nationwide are ditching harsh fluorescent lighting in favor of advanced systems designed to improve cognitive function and entice remote workers back to physical workplaces. Companies are investing in circadian-tuned lighting that adjusts intensity and color temperature throughout the day to mimic natural light patterns, syncing with employees' biological rhythms, according to WSJ. The technology arsenal includes faux skylights displaying virtual suns and moons, AI-controlled self-tinting windows, and customizable lighting zones that can be adjusted via remote control. Research suggests these innovations may improve brain function during tasks requiring sustained attention. "We've known for a long time that natural light is better and makes people feel better," says Peter Cappelli, professor at Wharton School. The innovations stem from discoveries in the early 2000s of photosensitive retinal cells that affect biology independent of vision. Industry specialists report a "huge uptick in requests," though implementation adds 20-30% to project costs, potentially slowing mainstream adoption. Read more of this story at Slashdot.
Offices nationwide are ditching harsh fluorescent lighting in favor of advanced systems designed to improve cognitive function and entice remote workers back to physical workplaces. Companies are investing in circadian-tuned lighting that adjusts intensity and color temperature throughout the day to mimic natural light patterns, syncing with employees' biological rhythms, according to WSJ.
The technology arsenal includes faux skylights displaying virtual suns and moons, AI-controlled self-tinting windows, and customizable lighting zones that can be adjusted via remote control. Research suggests these innovations may improve brain function during tasks requiring sustained attention. "We've known for a long time that natural light is better and makes people feel better," says Peter Cappelli, professor at Wharton School. The innovations stem from discoveries in the early 2000s of photosensitive retinal cells that affect biology independent of vision. Industry specialists report a "huge uptick in requests," though implementation adds 20-30% to project costs, potentially slowing mainstream adoption.
Read more of this story at Slashdot.
